RESUMEN
Meningiomas are among the most common primary tumors of the central nervous system. Previous research into the meningioma histological appearance, genetic markers, transcriptome and epigenetic landscape has revealed that benign meningiomas significantly differ in their glucose metabolism compared to aggressive lesions. However, a correlation between the systemic glucose metabolism and the metabolism of the tumor hasn't yet been found. We hypothesized that chronic levels of glycaemia (approximated with glycated hemoglobin (HbA1c)) are different in patients with aggressive and benign meningiomas. The study encompassed 71 patients with de novo intracranial meningiomas, operated on in three European hospitals, two in Croatia and one in Spain. Our results show that patients with WHO grade 2 meningiomas had significantly higher HbA1c values compared to patients with grade 1 lesions (P = 0.0290). We also found a significant number of patients (19/71; 26.7%) being hyperglycemic, harboring all the risks that such a condition entails. Finally, we found a significant correlation between our patients' age and their preoperative HbA1c levels (P = 0.0008, ρ(rho) = 0.388), suggesting that older meningioma patients are at a higher risk of having their glycaemia severely dysregulated. These findings are especially important considering the current routine and wide-spread use of corticosteroids as anti-edematous treatment. Further research in this area could lead to better understanding of meningiomas and have immediate clinical impact.
Asunto(s)
Hiperglucemia , Neoplasias Meníngeas , Meningioma , Humanos , Meningioma/cirugía , Hemoglobina Glucada , Neoplasias Meníngeas/cirugía , GlucosaRESUMEN
Multiple primary tumors in the central nervous system of different histological cell types are uncommon. We report a patient who had pilocytic astrocytoma in the cerebellum and ependymoma in the cauda equina region, occurring simultaneously. The suggested mechanism of this association is that primitive multipotent cells might have been displaced in the different CNS areas and developed in different tumor cells. Multiplicity of primary CNS tumors should be considered in certain occasions, when clinical symptoms and signs are pointing in that direction.
Asunto(s)
Astrocitoma/patología , Neoplasias Cerebelosas/patología , Ependimoma/patología , Neoplasias Primarias Múltiples/patología , Neoplasias de la Médula Espinal/patología , Adulto , Astrocitoma/cirugía , Cauda Equina/patología , Cauda Equina/cirugía , Neoplasias Cerebelosas/cirugía , Ependimoma/cirugía , Femenino , Humanos , Imagen por Resonancia Magnética , Neoplasias Primarias Múltiples/cirugía , Procedimientos Neuroquirúrgicos , Neoplasias de la Médula Espinal/cirugíaRESUMEN
Aspergillosis of the central nervous system (CNS) is a rare, but well described disease in immuno-competent patients. We present a 65-year-old patient who developed neuro-aspergillosis 10 months after severe cranio-facial trauma (Le Fort III). He was treated successfully with surgery including stereotactic drainage and, with Amphotericin B, Liposomal Amphotericin B, and Itraconazol.
Asunto(s)
Absceso Encefálico/inmunología , Traumatismos Faciales/cirugía , Inmunocompetencia/inmunología , Fracturas Maxilares/cirugía , Meningitis Fúngica/inmunología , Neuroaspergilosis/inmunología , Complicaciones Posoperatorias/inmunología , Fracturas Craneales/cirugía , Anciano , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Absceso Encefálico/diagnóstico , Absceso Encefálico/tratamiento farmacológico , Absceso Encefálico/cirugía , Ventrículos Cerebrales/cirugía , Derivaciones del Líquido Cefalorraquídeo , Terapia Combinada , Esquema de Medicación , Humanos , Hidrocefalia/cirugía , Itraconazol/administración & dosificación , Masculino , Meningitis Fúngica/diagnóstico , Meningitis Fúngica/tratamiento farmacológico , Meningitis Fúngica/cirugía , Microcirugia , Corteza Motora/cirugía , Neuroaspergilosis/diagnóstico , Neuroaspergilosis/tratamiento farmacológico , Neuroaspergilosis/cirugía , Neuronavegación , Osteotomía Le Fort , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/cirugía , Reoperación , Tomografía Computarizada por Rayos XRESUMEN
In 169 patients with all stages of endometrial cancer peritoneal cytology was performed and the finding correlated to the stage of disease, histologic grade, depth of myometrial invasion, tumor site in the uterine cavity, menstrual status, frequency of recurrence and 5-year survival. In 23 (11.6%) patients malignant cells were found in the peritoneal washing. In patients with Stage I endometrial cancer 6.5%, Stage II 9.1%, and in those in whom disease had spread outside the uterus (Stage III and IV) in 68.0% (p < 0.001). Positive peritoneal cytology was found significantly more frequently in patients with maintained menstrual cycle (p < 0.01), patients with tumor localized in uterine horns and in those patients with low values of steroid receptors. With regard to the histologic grade no difference was found in peritoneal cytology regardless of the stage of the disease. With regard to the myometrial invasion difference in the finding of malignant cells was found only in those patients in whom the tumor had spread outside the uterus (p < 0.05). Regardless of the stage of the disease, the frequency of recurrence and 5-year survival did not correlate with the finding of malignant cells in peritoneal lavage. According to our results the finding of peritoneal cytology, as an isolated prognostic factor, or in correlation with other prognostic factors, does not play an important role in the prognosis of patients with endometrial cancer, particularly those in whom the tumor is localized only in the uterus.
Asunto(s)
Líquido Ascítico/citología , Neoplasias Endometriales/patología , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias Endometriales/mortalidad , Femenino , Humanos , Persona de Mediana Edad , Invasividad Neoplásica , Recurrencia Local de Neoplasia , Estadificación de Neoplasias , Lavado Peritoneal , Posmenopausia , Premenopausia , Pronóstico , Análisis de SupervivenciaRESUMEN
The examination was carried out in 50 rosacea patients (30 females and 20 males) in order to establish the connexion between skin surface lipids, infestation with Demodex folliculorum and previous local corticosteroid treatment with the appearance of epitheloid granulomas. Our analysis showed three types of histological conditions: 1) chronic dermatitis of the rosacea type was noted in 15 patients (30%); 2) granulomas composed of epitheloid cells was found in 16 patients (32%). In three female patients of this group presence of caseous necrosis associated with epitheloid granuloma was noted, too; 3) prevalence of perifollicular absceses was found in 19 patients (38%). Demodex folliculorum was detected in 43 rosacea patients (86%), considerably more then in the control group. The normal value of the skin surface lipids was found in 9 female rosacea patients (30%) and in 9 female controls (43%), in 8 male rosacea patients (40%) and in 5 males controls (33%). Lower amounts of skin surface lipids were found in 19 female rosacea patients (63%) and in 9 female controls (43%), in 4 male rosacea patients (20%) and in 1 male control (7%). Higher amounts of skin surface lipids were found in 2 female rosacea patients (7%) and in 3 female controls (14%), in 8 male rosacea patients (40%) and in 9 male controls (60%). Lower quantities of lipids determined a higher incidence of Demodex folliculorum in rosacea patients. Demodex folliculorum were also more frequently detected in patients who had previously been treated with topical corticosteroids (even in 91.9%), what was often followed by epitheloid granulomas. The treatment with tetracycline yielded good or excellent results in 90% of all the patients.
Asunto(s)
Granuloma/metabolismo , Lípidos/análisis , Rosácea/metabolismo , Enfermedades de la Piel/metabolismo , Piel/química , Adulto , Anciano , Femenino , Granuloma/patología , Humanos , Masculino , Persona de Mediana Edad , Rosácea/patología , Piel/patología , Enfermedades de la Piel/patologíaRESUMEN
The concentrations of progesterone receptors in endometrial tumors of 160 patients were analyzed with respect to survival and presence of clinicopathologic prognostic factors. The concentration of 25 fmol/mg of proteins for progesterone receptors appeared to be most powerful for prediction of survival. The survival was also significantly correlated to age, depth of myometrial invasion and clinical stage of the tumor. Concentration of estrogen receptors could not be correlated with the probability of patients' actuarial survival.
Asunto(s)
Neoplasias Endometriales/química , Neoplasias Endometriales/mortalidad , Endometrio/química , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisis , Análisis Actuarial , Femenino , Humanos , Persona de Mediana Edad , Análisis Multivariante , Pronóstico , Factores de Riesgo , Tasa de SupervivenciaRESUMEN
Flow cytometric cell cycle analysis was performed on paraffin-embedded blocks from 49 patients with stage I endometrial carcinoma. Care was taken to separate tumor tissue from normal tissue in each specimen; normal tissue was used as a control for each individual specimen. DNA index, proliferative activity, and cell DNA aneuploidy were correlated with known parameters of tumor malignancy. Increased DNA index corresponded well with the DNA aneuploid tumors, poor tumor differentiation (G3), myometrial invasion of more than one-third, more malignant histologic type of tumor, and low concentration of estrogen (< or = 10 fmole/mg) and progesterone (< or = 25 fmole/mg) receptors. Similar results were obtained for tumor cell proliferative activity (percentage of cells in S + G2/M phases) and for DNA aneuploid tumors. Since more than 90% of patients with stage I endometrial carcinoma survived the 5-year postoperation period, analyzed parameters could not be checked for survival-related prognostic significance. However, our data indicate that cell cycle analysis may be instrumental for objective ranking of several known prognostic parameters.